Glaxo places PR business for HIV drugs under review

Share this article:

GlaxoSmithKline has placed the PR business for its HIV medications franchise in review.
The incumbent agency, Chicagobased PCI Public Communications, is not participating in the review.
A GSK spokeswoman declined to comment on the review, citing corporate policy that "any of our agency dealings is confidential."

 

Share this article:

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.